Always consult with a qualified healthcare provider for guidance tailored to your unique health profile
While not specifically approved for prediabetes, the metabolic improvements from Retatrutide should benefit individuals in this category
Sugesto de Uso !titulo= =conteudo
Most patients qualify for therapy if they have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea
If you must use a vial beyond 28 days, assume reduced potency and expect diminished outcomes, but the more reliable approach is to reconstitute smaller vials more frequently
The standard Phase 2 trial schedule began at 0.5 to 1mg weekly, escalating every 4 weeks through 2mg, 4mg, 8mg, and up to 12mg